drugset / Trial / NCT02033876
Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate whether bile acids are able to increase insulin sensitivity and enhance glycemic control in T2DM patients, as well as exploring the mechanisms that enhance glycemic control. These observations will provide the preliminary data for proposing future therapeutic as well as further mechanistic studies of the role of bile acids in the control of glycemia in T2DM.
Timeline
- Start
- 2013-10
- Primary completion
- 2017-01
- Completion
- 2017-03
Outcome
Missed primary endpoint
registry analysis (superiority test); Ursodiol vs Placebo; p = 0.43; ANCOVA NCT02033876 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ursodeoxycholic Acid | Small molecule | 600 mg | — |